Essay - Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of...


Copyright Notice

Pfizer SWOT

Pfizer—a SWOT Analysis

*****

Pfizer is one of the world's leading research pharmaceutical companies and also one of the ***** most pr*****itable companies. It has a well-respected name known all over the world and commands some of ***** top *****, advertising, financial, and marketing talent. ***** produces two of the most well-known *****-brand drugs, Viagra and Lipitor in America today. Even the American Heart Association recommends ***** use of ***** such as Lipitor to reduce cholesterol when diet ***** exercise fail ***** reduce this common health problem. High cholesterol ***** a common ***** problem is only likely to *****crease with the rapidly aging population—and the rise in obesity levels (Berenson, 2007).

Weaknesses

Unfortunately, "while the company remains highly profitable, its financial health is increasingly tied to Lipitor" which is dangerous for the ***** in the future as Lipitor's patent will expire ***** several years, which means it will face competition from cheaper, generic drugs (*****, 2007). Pfizer's reputation has ***** been tainted by ***** association with Celebrex, a pain medication that has been tied to increased risk of heart problems, in comparison to over-the-counter painkillers. The prominence ***** the Pfizer advertising campaign for ***** drug, followed by its rapid f***** from grace undoubtedly damaged the company's trusted name.

Pfizer also manufactures Zoloft, an antidepressant that was widely criticized for its over-prescription to teenager, and possibly causing increased suicidal thoughts in this population. ***** company website now states that the drug is not advised for people under the age of 17. Antidepressants ***** 'lifestyle' ********** like Viagra have come ***** increased media scrutiny and ********** as examples of the over-prescription of medication in the American healthcare system ***** general. Healthcare in America is grow*****g more and more expensive, and insurance companies are being pressured to cut costs, including scaling back how much they pay ***** drugs.

Now, Exubera, "the first ***** so far ***** commercially available inhaled-insulin diabetes treatment," is on ***** verge ***** turning in***** an "expensive failure" as Pfizer "***** been dogged by questi*****s about its safety, cost and convenience" (Berenson, *****).

Opportunities

According to the ***** press release section of its website, discomfort associated with fibromyaglia, a ***** chronic pain condition, has ***** shown ***** be significantly reduced by a new drug developed by Pfizer called Lyrica, "according to study results presented today at the American Academy of Neurology annual meeting" ("Lyrica Significantly Reduced Pain," 2007, Press Release). Pfizer has also developed a new AIDS drug ***** Maraviroc, which is likely to considerably improve ***** extend the life ***** AIDS patients who take the *****, ***** ***** researchers at the University of Pittsburg and Columbia University (Altman & Pollock, 2007).

Threats

Both Merck and Schering-Plough, two ***** Pfizer's greatest rivals, plan to combine forces and develop a medicine ***** rival Lipitor. "The planned drug, meant to reduce levels of ***** harmful type of cholesterol in two ways, could hit the market when ***** patent expires in a few years" ("Merck and Schering-Plough Plan A*****her Cholesterol Drug,"

. . . . [END OF DISSERTATION PREVIEW]

Download full paper (and others like it)    |    Order a brand new, custom-written paper

© 2001–2015   |   Term Paper on Pfizer SWOT Pfizer—a SWOT Analysis Strengths Pfizer is One of   |   Essay Models